IRADIMED CORP
corporate_fare Company Profile
IRADIMED CORP (NASDAQ:IRMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for IRMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for IRMD spans 10-Q, 8-K, 144, 10-K.
Recent high-impact activity:
- iRadimed 10-Q Details Record Q3: $24.2M Revenue, $0.51 EPS, $0.20 Dividend
- iRadimed Posts Record $24.2M Q3 Revenue, Narrows Full-Year Guidance and Declares $0.20 Dividend
- iRadimed Posts 51-Cent Q3 EPS, Topping Prior Quarter's 41 Cents
- iRadimed Launches New 3870 MR IV Pump, Guides Q3 Revenue Up 12-20%
- IRADIMED Q2 2026: Revenue Meets Mark, EPS Slips; Full-Year Outlook Holds Steady
Financial Snapshot
Short Interest & Short Volume
5.10 days to coverFINRA reported short interest of 590,054 shares in IRMD as of the October 30, 2026 settlement, a 12.0% decrease from the prior period — about 5.1 days to cover at its recent average daily volume. On November 20, 2026, 63.0% of IRMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.